This study demonstrates for the first time that there exists an association between cytokines and cognition in patients with breast cancer, prior to any treatment.

This study demonstrates for the first time that there exists an association between cytokines and cognition in patients with breast cancer, prior to any treatment.

This study demonstrates for the first time that there exists an association between cytokines and cognition in patients with breast cancer, prior to any treatment.

Results of the primary multivariable analyses and subsequent post-hoc analyses found that higher TNF, as measured by sTNF-RII, predicted reduced memory performance in patients.

we observed cognitive impairment in newly diagnosed patients with breast cancer at a pretreatment evaluation